Related Experiment Video
Updated: Feb 4, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Day-case percutaneous left atrial appendage occlusion-Safety and efficacy
Timothy Williams1, Osama Alsanjari1, Jessica Parker1
1Department of Cardiology, Sussex Cardiac Centre, Brighton and Sussex University Hospitals, United Kingdom.
Insights
Percutaneous left atrial appendage (LAA) occlusion is safe and effective as a day case procedure. This approach reduces hospital stays without increasing complication risks for stroke prevention in atrial fibrillation patients.
Area of Science:
- Cardiology
- Interventional Cardiology
- Medical Device Technology
Background:
- Left atrial appendage (LAA) occlusion is a proven method for stroke prevention in patients with atrial fibrillation.
- The feasibility of performing LAA occlusion as a day-case procedure remains to be established.
Purpose of the Study:
- To evaluate the safety and efficacy of percutaneous LAA occlusion when performed as a day-case procedure.
- To assess complication rates and length of stay for same-day discharge after LAA occlusion.
Main Methods:
- Retrospective analysis of 117 LAA occlusion procedures in a UK teaching hospital.
- Examination of procedural success, complication rates, length of stay, and readmission data.
- Post-procedure echocardiography performed 2-4 hours before discharge.
Main Results:
- Successful device deployment in 99% of patients.
- Major in-hospital complications occurred in 1.7% of patients (femoral vascular access).
- 66% of patients were discharged on the same day; only 5% stayed overnight after January 2016.
Conclusions:
- Percutaneous LAA occlusion can be safely performed as a day-case procedure.
- Day-case LAA occlusion is associated with acceptable complication rates.
- No increase in complications was observed due to the lack of routine overnight stay.
Objectives:
We evaluated the safety and efficacy of percutaneous left atrial appendage (LAA) occlusion performed as a day case procedure.
Background:
LAA occlusion has been shown to be safe and effective for stroke prevention in patients with atrial fibrillation. It has not been shown if the procedure can safely be performed on a day-case basis.
Methods:
Retrospective analysis was made of 117 LAA occlusion procedures in a single large teaching hospital in the UK. Procedural success, procedural complications, length of stay, and readmission data were examined.
Results:
Successful deployment of a device was possible in all but one patient (whose appendage was too large). Major in-hospital complications occurred in 1.7% of patients (both femoral vascular). Same-day discharge was made in 66% of patients overall. Since January 2016, only 3 of 59 patients (5%) have remained in hospital overnight following LAAO. Echocardiography 2-4 hr postprocedure was undertaken prior to discharge. One patient was readmitted within 7 days but this readmission would not have been prevented by overnight stay.
Conclusions:
LAA occlusion can be safely performed as a day case procedure with acceptable complication rates and no increment of complications related to the lack of routine overnight stay.
Related Concept Videos
Surface Appendages of Archaea
Survey Safety
Self-Efficacy
Household Wiring And Electrical Safety
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Dose-Response Relationship: Potency and Efficacy

